NYSE:ABTMedical Equipment
Abbott Laboratories (NYSE:ABT) Expands Diabetes Care with FreeStyle Libre 3 Plus Launch in Canada
Abbott Laboratories (NYSE:ABT) recently introduced the FreeStyle Libre 3 Plus in Canada, marking an advancement in diabetes management technology with its small, sensor-based glucose monitoring system. This development, alongside other approvals and partnerships like the i-STAT TBI test and mitral valve replacement system, may have bolstered investor confidence contributing to the company's quarterly share price growth of almost 5%. However, against a backdrop of generally rising market...